Literature DB >> 7350844

Surgery in oculopharyngeal muscular dystrophy.

A Duranceau, M D Forand, J P Fauteux.   

Abstract

Oculpharyngeal muscular dystrophy is an autosomal dominant inherited condition seen mainly in patients of French Canadian origin. Fifteen patients with an established diagnosis of the disease were evaluated clinically, manometrically and radiologically before and after cricopharyngeal myotomy. All patients presented with oropharyngeal dysphagia to solids and liquids, pharyngooral and pharyngonasal regurgitation, frequent aspiration at mealtime and chronic aspiration of saliva during the night. When compared with a control group, significant differences were observed in the pressure, duration and frequency of pharyngeal contraction. Cricopharyngeal myotomy did not alter pharyngeal function. At the level of the upper esophageal sphincter, resting and contraction pressure relaxation, relaxation time and coordination were examined. Relaxation time was the only significant abnormality observed between patients with oculopharyngeal muscular dystrophy and control subjects. Surgery significantly lowered the resting and contracting pressures of the sphincter. Relaxation time was brought toward normal. All patients' symptoms were significantly improved by cricopharyngeal myotomy.

Entities:  

Mesh:

Year:  1980        PMID: 7350844     DOI: 10.1016/0002-9610(80)90226-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.

Authors:  Sophie Périé; Capucine Trollet; Vincent Mouly; Valérie Vanneaux; Kamel Mamchaoui; Belaïd Bouazza; Jean Pierre Marolleau; Pascal Laforêt; Françoise Chapon; Bruno Eymard; Gillian Butler-Browne; Jérome Larghero; Jean Lacau St Guily
Journal:  Mol Ther       Date:  2013-07-08       Impact factor: 11.454

2.  Dysphagia caused by ptosis.

Authors:  Koichi Tsunoda; Hiroko Satoh; Yoko Morita
Journal:  BMJ Case Rep       Date:  2009-02-16

3.  Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.

Authors:  Sarah Youssof; Ronald M Schrader; Carol Romero-Clark; Gulmohor Roy; Michael Spafford
Journal:  Muscle Nerve       Date:  2014-02-25       Impact factor: 3.217

4.  A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD).

Authors:  Ashley A Waito; Catriona M Steele; Melanie Peladeau-Pigeon; Angela Genge; Zohar Argov
Journal:  Dysphagia       Date:  2018-05-03       Impact factor: 3.438

5.  Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument.

Authors:  Sarah Youssof; Carol Romero-Clark; Teddy Warner; Emily Plowman
Journal:  Muscle Nerve       Date:  2017-02-12       Impact factor: 3.217

6.  Oculopharyngeal dystrophy: ultrastructure of muscles distinct from the primary myopathy.

Authors:  J W Kozachek; F J Wilson
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

Review 7.  Oculopharyngeal muscular dystrophy: a polyalanine myopathy.

Authors:  Bernard Brais
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

8.  Cervical esophageal dysphagia: indications for and results of cricopharyngeal myotomy.

Authors:  F H Ellis; R E Crozier
Journal:  Ann Surg       Date:  1981-09       Impact factor: 12.969

9.  Cross-cultural adaptation of the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French-Canadian and preliminary assessment for their use in an oculopharyngeal muscular dystrophy (OPMD) population.

Authors:  Claudia Côté; Julie Fortin; Bernard Brais; Sarah Youssof; Cynthia Gagnon
Journal:  Qual Life Res       Date:  2021-07-22       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.